The global Surgical Hemostatic Material market size was valued at US$ 2330 million in 2024 and is forecast to a readjusted size of USD 3018 million by 2031 with a CAGR of 3.8% during review period.
Surgical hemostatic material is听used to control bleeding intraoperatively.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report is a detailed and comprehensive analysis for global Surgical Hemostatic Material market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Surgical Hemostatic Material market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Surgical Hemostatic Material market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Surgical Hemostatic Material market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Surgical Hemostatic Material market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Surgical Hemostatic Material
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Surgical Hemostatic Material market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, BD, Baxter, B.Braun, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences, Zhonghui Shengxi, Beijing Datsing Bio-tech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Surgical Hemostatic Material market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Hemostatic Gauze
Gelatin Sponge
Styptic Powder
麻豆原创 segment by Application
Hospital
Clinic
Other
Major players covered
Johnson & Johnson
BD
Baxter
B.Braun
Cura Medical
GELITA MEDICAL
Curasan AG
Meril Life Sciences
Zhonghui Shengxi
Beijing Datsing Bio-tech
Guizhou Jin Jiu Biotech
Beijing Taikesiman
Foryou Medical
Saikesaisi Holdings Group
Biotemed
Hangzhou Singclean Medical Products
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Surgical Hemostatic Material product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Surgical Hemostatic Material, with price, sales quantity, revenue, and global market share of Surgical Hemostatic Material from 2020 to 2025.
Chapter 3, the Surgical Hemostatic Material competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Surgical Hemostatic Material breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Surgical Hemostatic Material market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Surgical Hemostatic Material.
Chapter 14 and 15, to describe Surgical Hemostatic Material sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Surgical Hemostatic Material Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Hemostatic Gauze
1.3.3 Gelatin Sponge
1.3.4 Styptic Powder
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Surgical Hemostatic Material Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Surgical Hemostatic Material 麻豆原创 Size & Forecast
1.5.1 Global Surgical Hemostatic Material Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Surgical Hemostatic Material Sales Quantity (2020-2031)
1.5.3 Global Surgical Hemostatic Material Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Surgical Hemostatic Material Product and Services
2.1.4 Johnson & Johnson Surgical Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Johnson & Johnson Recent Developments/Updates
2.2 BD
2.2.1 BD Details
2.2.2 BD Major Business
2.2.3 BD Surgical Hemostatic Material Product and Services
2.2.4 BD Surgical Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 BD Recent Developments/Updates
2.3 Baxter
2.3.1 Baxter Details
2.3.2 Baxter Major Business
2.3.3 Baxter Surgical Hemostatic Material Product and Services
2.3.4 Baxter Surgical Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Baxter Recent Developments/Updates
2.4 B.Braun
2.4.1 B.Braun Details
2.4.2 B.Braun Major Business
2.4.3 B.Braun Surgical Hemostatic Material Product and Services
2.4.4 B.Braun Surgical Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 B.Braun Recent Developments/Updates
2.5 Cura Medical
2.5.1 Cura Medical Details
2.5.2 Cura Medical Major Business
2.5.3 Cura Medical Surgical Hemostatic Material Product and Services
2.5.4 Cura Medical Surgical Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Cura Medical Recent Developments/Updates
2.6 GELITA MEDICAL
2.6.1 GELITA MEDICAL Details
2.6.2 GELITA MEDICAL Major Business
2.6.3 GELITA MEDICAL Surgical Hemostatic Material Product and Services
2.6.4 GELITA MEDICAL Surgical Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 GELITA MEDICAL Recent Developments/Updates
2.7 Curasan AG
2.7.1 Curasan AG Details
2.7.2 Curasan AG Major Business
2.7.3 Curasan AG Surgical Hemostatic Material Product and Services
2.7.4 Curasan AG Surgical Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Curasan AG Recent Developments/Updates
2.8 Meril Life Sciences
2.8.1 Meril Life Sciences Details
2.8.2 Meril Life Sciences Major Business
2.8.3 Meril Life Sciences Surgical Hemostatic Material Product and Services
2.8.4 Meril Life Sciences Surgical Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Meril Life Sciences Recent Developments/Updates
2.9 Zhonghui Shengxi
2.9.1 Zhonghui Shengxi Details
2.9.2 Zhonghui Shengxi Major Business
2.9.3 Zhonghui Shengxi Surgical Hemostatic Material Product and Services
2.9.4 Zhonghui Shengxi Surgical Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Zhonghui Shengxi Recent Developments/Updates
2.10 Beijing Datsing Bio-tech
2.10.1 Beijing Datsing Bio-tech Details
2.10.2 Beijing Datsing Bio-tech Major Business
2.10.3 Beijing Datsing Bio-tech Surgical Hemostatic Material Product and Services
2.10.4 Beijing Datsing Bio-tech Surgical Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Beijing Datsing Bio-tech Recent Developments/Updates
2.11 Guizhou Jin Jiu Biotech
2.11.1 Guizhou Jin Jiu Biotech Details
2.11.2 Guizhou Jin Jiu Biotech Major Business
2.11.3 Guizhou Jin Jiu Biotech Surgical Hemostatic Material Product and Services
2.11.4 Guizhou Jin Jiu Biotech Surgical Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 Guizhou Jin Jiu Biotech Recent Developments/Updates
2.12 Beijing Taikesiman
2.12.1 Beijing Taikesiman Details
2.12.2 Beijing Taikesiman Major Business
2.12.3 Beijing Taikesiman Surgical Hemostatic Material Product and Services
2.12.4 Beijing Taikesiman Surgical Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 Beijing Taikesiman Recent Developments/Updates
2.13 Foryou Medical
2.13.1 Foryou Medical Details
2.13.2 Foryou Medical Major Business
2.13.3 Foryou Medical Surgical Hemostatic Material Product and Services
2.13.4 Foryou Medical Surgical Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 Foryou Medical Recent Developments/Updates
2.14 Saikesaisi Holdings Group
2.14.1 Saikesaisi Holdings Group Details
2.14.2 Saikesaisi Holdings Group Major Business
2.14.3 Saikesaisi Holdings Group Surgical Hemostatic Material Product and Services
2.14.4 Saikesaisi Holdings Group Surgical Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.14.5 Saikesaisi Holdings Group Recent Developments/Updates
2.15 Biotemed
2.15.1 Biotemed Details
2.15.2 Biotemed Major Business
2.15.3 Biotemed Surgical Hemostatic Material Product and Services
2.15.4 Biotemed Surgical Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.15.5 Biotemed Recent Developments/Updates
2.16 Hangzhou Singclean Medical Products
2.16.1 Hangzhou Singclean Medical Products Details
2.16.2 Hangzhou Singclean Medical Products Major Business
2.16.3 Hangzhou Singclean Medical Products Surgical Hemostatic Material Product and Services
2.16.4 Hangzhou Singclean Medical Products Surgical Hemostatic Material Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.16.5 Hangzhou Singclean Medical Products Recent Developments/Updates
3 Competitive Environment: Surgical Hemostatic Material by Manufacturer
3.1 Global Surgical Hemostatic Material Sales Quantity by Manufacturer (2020-2025)
3.2 Global Surgical Hemostatic Material Revenue by Manufacturer (2020-2025)
3.3 Global Surgical Hemostatic Material Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Surgical Hemostatic Material by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Surgical Hemostatic Material Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Surgical Hemostatic Material Manufacturer 麻豆原创 Share in 2024
3.5 Surgical Hemostatic Material 麻豆原创: Overall Company Footprint Analysis
3.5.1 Surgical Hemostatic Material 麻豆原创: Region Footprint
3.5.2 Surgical Hemostatic Material 麻豆原创: Company Product Type Footprint
3.5.3 Surgical Hemostatic Material 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Surgical Hemostatic Material 麻豆原创 Size by Region
4.1.1 Global Surgical Hemostatic Material Sales Quantity by Region (2020-2031)
4.1.2 Global Surgical Hemostatic Material Consumption Value by Region (2020-2031)
4.1.3 Global Surgical Hemostatic Material Average Price by Region (2020-2031)
4.2 North America Surgical Hemostatic Material Consumption Value (2020-2031)
4.3 Europe Surgical Hemostatic Material Consumption Value (2020-2031)
4.4 Asia-Pacific Surgical Hemostatic Material Consumption Value (2020-2031)
4.5 South America Surgical Hemostatic Material Consumption Value (2020-2031)
4.6 Middle East & Africa Surgical Hemostatic Material Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Surgical Hemostatic Material Sales Quantity by Type (2020-2031)
5.2 Global Surgical Hemostatic Material Consumption Value by Type (2020-2031)
5.3 Global Surgical Hemostatic Material Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Surgical Hemostatic Material Sales Quantity by Application (2020-2031)
6.2 Global Surgical Hemostatic Material Consumption Value by Application (2020-2031)
6.3 Global Surgical Hemostatic Material Average Price by Application (2020-2031)
7 North America
7.1 North America Surgical Hemostatic Material Sales Quantity by Type (2020-2031)
7.2 North America Surgical Hemostatic Material Sales Quantity by Application (2020-2031)
7.3 North America Surgical Hemostatic Material 麻豆原创 Size by Country
7.3.1 North America Surgical Hemostatic Material Sales Quantity by Country (2020-2031)
7.3.2 North America Surgical Hemostatic Material Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Surgical Hemostatic Material Sales Quantity by Type (2020-2031)
8.2 Europe Surgical Hemostatic Material Sales Quantity by Application (2020-2031)
8.3 Europe Surgical Hemostatic Material 麻豆原创 Size by Country
8.3.1 Europe Surgical Hemostatic Material Sales Quantity by Country (2020-2031)
8.3.2 Europe Surgical Hemostatic Material Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Surgical Hemostatic Material Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Surgical Hemostatic Material Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Surgical Hemostatic Material 麻豆原创 Size by Region
9.3.1 Asia-Pacific Surgical Hemostatic Material Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Surgical Hemostatic Material Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Surgical Hemostatic Material Sales Quantity by Type (2020-2031)
10.2 South America Surgical Hemostatic Material Sales Quantity by Application (2020-2031)
10.3 South America Surgical Hemostatic Material 麻豆原创 Size by Country
10.3.1 South America Surgical Hemostatic Material Sales Quantity by Country (2020-2031)
10.3.2 South America Surgical Hemostatic Material Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Surgical Hemostatic Material Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Surgical Hemostatic Material Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Surgical Hemostatic Material 麻豆原创 Size by Country
11.3.1 Middle East & Africa Surgical Hemostatic Material Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Surgical Hemostatic Material Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Surgical Hemostatic Material 麻豆原创 Drivers
12.2 Surgical Hemostatic Material 麻豆原创 Restraints
12.3 Surgical Hemostatic Material Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Surgical Hemostatic Material and Key Manufacturers
13.2 Manufacturing Costs Percentage of Surgical Hemostatic Material
13.3 Surgical Hemostatic Material Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Surgical Hemostatic Material Typical Distributors
14.3 Surgical Hemostatic Material Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Johnson & Johnson
BD
Baxter
B.Braun
Cura Medical
GELITA MEDICAL
Curasan AG
Meril Life Sciences
Zhonghui Shengxi
Beijing Datsing Bio-tech
Guizhou Jin Jiu Biotech
Beijing Taikesiman
Foryou Medical
Saikesaisi Holdings Group
Biotemed
Hangzhou Singclean Medical Products
听
听
*If Applicable.
